Återigen stor ära för Resesammanslutning av TSS
7.10.2025 13:42:09 CEST | news aktuell GmbH | Press Release

Återigen kan RSD Travel – partnerföretaget till TSS Travel Service Scandinavia – glädja sig åt en särskild utmärkelse på den hårt konkurrensutsatta brittiska resemarknaden: RSD Travel har nyligen tilldelats Midlands Enterprise Award. Och det som „International Cultural Tour Operator of the Year 2025“ – som „Internationell kulturresearrangör för år 2025“.
Redan förra året kunde RSD Travel som en av de bästa kulturresearrangörerna erövra det prestigefyllda British Travel Award.
Den aktuella utmärkelsen delas ut av SME News, en mycket uppmärksammad tidskrift för brittiska företagsledare och experter, stödd av ett nätverk av branschinsiders. Med utmärkelsen intygar man att RSD Travel intar en framstående position i denna mycket krävande miljö. För detta pris hedrar företag som verkligen gör skillnad i sina branscher, som går i bräschen „inom innovation, utmärkt kundservice eller effektiva hållbarhetsinitiativ“. De hedrar dem som „överskrider gränser och sätter standarder för excellens“. Pristagarna, betonas det, väljs uteslutande efter meritprincipen, för att säkerställa att endast de mest förtjänta kandidaterna kommer i fråga. För RSD Travel, som en av de ledande europeiska kulturresearrangörerna, visar denna återkommande brittiska uppskattning: Topp-prestationer i resebranschen uppmärksammas och erkänns – av semesterfirare såväl som av reseproffs.
Rud, Norge
Contacts
Telefon: +46 844 685 504
e-post: info@tss-travel.se
Images
Subscribe to releases from news aktuell GmbH
Subscribe to all the latest releases from news aktuell GmbH by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from news aktuell GmbH
Webasto Air Top Pro 25: a new, exceptionally quiet parking heater for campers22.10.2026 13:28:00 CEST | Press Release
Why should the camping season end just because summer is over? The colder months offer unique experiences—from skiing and snowshoeing to simply enjoying the winter landscape. To ensure your motorhome or campervan remains a comfortable retreat even in low temperatures, the right heating solution is crucial.
Polarise Launches Sovereign AI Cloud at NVIDIA GTC Berlin, Delivering Enterprise AI From Data Center to Application22.10.2026 10:00:00 CEST | Press Release
With Polarise Rise and Polarise Drive, the German AI provider extends its own European AI Factories into a full-stack sovereign cloud
Fiscal strength doesn't guarantee public goods delivery, US study finds21.10.2026 09:28:38 CEST | Press Release
New York/DNA - A newly released study of US state government performance found strong partisan and regional patterns within three pillars of governance: democratic accountability, state capacity and public goods provision. Yet, the US states’ outcomes differ in important ways from international comparisons, as the three governance dimensions show limited correlation, the researchers found. The report, “The Governance Performance of the Fifty States: The U.S. Berggruen Governance Index”, applies the research team’s “governance triangle” from past global country rankings to the 50 US states. The report has now been presented to the public at Columbia University in New York. “Unlike in the Berggruen Governance Index’s cross-national comparisons, where the three dimensions are broadly correlated, in the 50 U.S. states they often run counter to each other,” the authors conclude. “This may seem counterintuitive, as one might expect a well-governed state to finish high on all three and a poor
agineo expands partnership with ServiceNow, launches AI Control Tower as a Service20.10.2026 12:48:13 CEST | Press Release
New managed service provides transparency into the AI landscape and helps companies centrally manage AI, monitor risks and regulatory requirements, and highlight business benefits.
Grünenthal advances proprietary Nociceptin Receptor (NOP) Agonist into Phase II trial in acute pain20.10.2026 09:23:41 CEST | Press Release
Potential first-in-class, selective nociceptin receptor (NOP) agonist that aims to provide safe, effective treatment for moderate to severe acute pain. Following successful Phase I results earlier this year demonstrating an excellent safety profile, the program has now progressed to Phase II. The randomized, double-blind, double-dummy, placebo- and active controlled, 2-part Phase II trial will evaluate the safety, tolerability and efficacy of this novel NOP agonist in patients post bunionectomy surgery. Grünenthal anticipates reporting results in early 2028.
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom